Fernández-Llaneza, Daniel
Gondová, Andrea
Vince, Harris
Patra, Arijit
Zurek, Magdalena
Konings, Peter
Kagelid, Patrik
Hultin, Leif
Funding for this research was provided by:
AstraZeneca
Article History
Received: 8 September 2021
Accepted: 26 April 2022
First Online: 2 June 2022
Competing interests
: Daniel Fernández-Llaneza, Peter Konings, Leif Hultin, Patrik Kagelid and Harris Vince are employees of AstraZeneca and may own stock options. No competing interests apply for Andrea Gondová, Arijit Patra or Magdalena Zurek.